Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Terbutaline (2.5mg) Tablet
Therapeutic Category
Respiratory
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Terabute 2.5 Tablet containing Terbutaline is used for the management of respiratory conditions associated with bronchospasm and airway narrowing. It helps improve airflow and supports easier breathing.
Terbutaline works as a selective beta-2 adrenergic agonist that relaxes the smooth muscles of the airways, helping open the bronchial passages and reduce breathing difficulties.
The tablet is widely prescribed in respiratory and general medicine practice for conditions requiring bronchodilator therapy, leading to consistent prescription demand.
With increasing prevalence of respiratory disorders and growing demand for effective airway management therapies, this product offers strong business potential for retailers and distributors. Its established bronchodilator action, broad clinical relevance, and steady market demand make it a reliable product for growth in the respiratory care segment.
Some patients may experience tremors, nervousness, headache, palpitations, increased heart rate, dizziness, or muscle cramps. Rarely, severe allergic reactions, chest pain, significant cardiac rhythm disturbances, or low potassium levels may occur and require immediate medical attention.
Terabute 2.5 Tablet is indicated for bronchial asthma, chronic obstructive pulmonary disease (COPD), bronchospasm, wheezing, and other respiratory conditions associated with reversible airway obstruction. It helps relieve shortness of breath, chest tightness, and breathing difficulties.
This medicine should be used strictly under medical supervision. Use cautiously in patients with heart disease, hypertension, diabetes, hyperthyroidism, or seizure disorders. Excessive use may increase the risk of cardiovascular side effects. Follow the prescribed dosage carefully and report any worsening of respiratory symptoms promptly.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Ambroxol (30mg) + Cetirizine (5mg) + Dextromethorphan Hydrobromide (10mg) + Guaifenesin (100mg) + Phenylephrine (15mg)
Composition : Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Levocetirizine (2.5mg/5ml) + Menthol (1mg/5ml)
Composition : Ambroxol (7.5mg) + Guaifenesin (12.5mg) + Terbutaline (0.25mg)
Composition : Ambroxol (10mg/5ml) + Guaifenesin (25mg/5ml) + Terbutaline (0.5mg/5ml)
Composition : Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Menthol (2.5mg/5ml) + Terbutaline (1.25mg/5ml)
Composition : Terbutaline Sulphate I.P. 1.25mg + Bromhexine HCL I.P. 2mg + Guaiphenesin I.P. 50mg + Menthol I.P. 0.5mg
Composition : Levodropropizine I.P. 30mg + Chlorpheniramine I.P. 2mg syrup
Composition : Phenylephrine (5mg) + Chlorpheniramine Maleate (2mg) + Dextromethorphan Hydrobromide (10mg)
Composition : Diphenhydramine HCL I.P. 14.08mg + Ammonium Chloride I.P. 138.00mg + Sodium Citrate I.P. 57.03mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.